A Bioequivalence Study Of Ibuprofen 50mg/ml (laboratórios Pfizer Ltda) In The Oral Suspension Form.

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 31, 2011

Primary Completion Date

May 31, 2011

Study Completion Date

May 31, 2011

Conditions

Healthy

Interventions

DRUG

Alivium®

400mg of Ibuprofen equivalent to 8mL (50mg/mL) oral suspension of the Reference Drug

DRUG

Ibuprofen

400mg of Ibuprofen equivalent to 8mL (50mg/mL) oral suspension of the Test Drug

Trial Locations (1)

Pfizer Investigational Site, Aparecida de Goiânia